Statement Of Financial Position [Abstract]
| Concept |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Statement of financial position [abstract] | |||||||||||||||||||||||||||
| Assets [abstract] | |||||||||||||||||||||||||||
| Non-current assets [abstract] | |||||||||||||||||||||||||||
| Property, plant and equipment | — |
93 711
EUR
|
— | — | — | — | — | — | — | — | — | — |
92 053
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Right-of-use assets | — |
48 322
EUR
|
— | — | — | — | — | — | — | — | — | — |
47 204
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Investments accounted for using equity method | — |
57,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
57,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Non-current biological assets | — |
10 515
EUR
|
— | — | — | — | — | — | — | — | — | — |
9 993
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Trade and other non-current receivables | — |
518,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
449,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax assets | — |
2 919
EUR
|
— | — | — | — | — | — | — | — | — | — |
2 089
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Non-current assets | — |
161 285
EUR
|
— | — | — | — | — | — | — | — | — | — |
155 330
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets [abstract] | |||||||||||||||||||||||||||
| Current inventories | — |
35 241
EUR
|
— | — | — | — | — | — | — | — | — | — |
24 096
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Trade and other current receivables | — |
7 832
EUR
|
— | — | — | — | — | — | — | — | — | — |
6 539
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current biological assets | — |
19 883
EUR
|
— | — | — | — | — | — | — | — | — | — |
19 398
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash and cash equivalents | — |
3 337
EUR
|
— | — | — | — | — | — | — | — | — | — |
2 446
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — |
2 541
EUR
|
| Current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners | — |
70 133
EUR
|
— | — | — | — | — | — | — | — | — | — |
56 834
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Non-current assets or disposal groups classified as held for sale or as held for distribution to owners | — |
-
EUR
|
— | — | — | — | — | — | — | — | — | — |
315,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | — |
70 133
EUR
|
— | — | — | — | — | — | — | — | — | — |
57 149
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Assets | — |
231 418
EUR
|
— | — | — | — | — | — | — | — | — | — |
212 479
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Equity and liabilities [abstract] | |||||||||||||||||||||||||||
| Equity [abstract] | |||||||||||||||||||||||||||
| Issued capital | — |
66 617
EUR
|
— | — | — | — | — | — | — | — | — | — |
65 951
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | — |
14 654
EUR
|
— | — | — | — | — | — | — | — | — | — |
9 329
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share premium | — |
6 707
EUR
|
— | — | — | — | — | — | — | — | — | — |
6 707
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Equity attributable to owners of parent | — |
77 105
EUR
|
— | — | — | — | — | — | — | — | — | — |
78 622
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Non-controlling interests | — |
428,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
358,000
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Equity |
2 041
EUR
|
77 533
EUR
|
13 565
EUR
|
428,000
EUR
|
6 707
EUR
|
2 829
EUR
|
14 654
EUR
|
66 617
EUR
|
77 105
EUR
|
2 041
EUR
|
10 251
EUR
|
9 328
EUR
|
78 980
EUR
|
78 623
EUR
|
6 707
EUR
|
3 002
EUR
|
358,000
EUR
|
65 951
EUR
|
1 834
EUR
|
366,000
EUR
|
9 213
EUR
|
6 237
EUR
|
92 450
EUR
|
65 951
EUR
|
6 707
EUR
|
2 509
EUR
|
92 816
EUR
|
| Liabilities [abstract] | |||||||||||||||||||||||||||
| Non-current liabilities [abstract] | |||||||||||||||||||||||||||
| Deferred tax liabilities | — |
1 863
EUR
|
— | — | — | — | — | — | — | — | — | — |
1 553
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Non-current liabilities | — |
83 236
EUR
|
— | — | — | — | — | — | — | — | — | — |
88 414
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current liabilities [abstract] | |||||||||||||||||||||||||||
| Trade and other current payables | — |
25 352
EUR
|
— | — | — | — | — | — | — | — | — | — |
19 482
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current liabilities | — |
70 649
EUR
|
— | — | — | — | — | — | — | — | — | — |
45 085
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Liabilities | — |
153 885
EUR
|
— | — | — | — | — | — | — | — | — | — |
133 499
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Equity and liabilities | — |
231 418
EUR
|
— | — | — | — | — | — | — | — | — | — |
212 479
EUR
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |